0.57Open0.57Pre Close0 Volume7 Open Interest35.00Strike Price0.00Turnover500.34%IV54.94%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.57Extrinsic Value100Contract SizeAmericanOptions Type-0.0324Delta0.0019Gamma134.05Leverage Ratio-0.3385Theta-0.0003Rho-4.35Eff Leverage0.0054Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet